Fig. 3
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12902-021-00797-4/MediaObjects/12902_2021_797_Fig3_HTML.png)
a Mean change in cross-reactive ADA by visit using the MYL-1501D assay in INSTRIDE 1a and b actual median cross-reactive ADA by visit using the MYL-1501D assay in INSTRIDE 2.b ADA, antidrug antibodies; BL, baseline; %SB, percentage specific binding. aError bars represent the SD. bError bars represent the interquartile range